Abstract | OBJECTIVE: MATERIALS AND METHODS: We treated 102 patients with subacromial impingement syndrome, diagnosed by physical examination and a subacromial lidocaine injection test, with a standardized conservative protocol. We followed the patients for a period of 12 months. Outcome was evaluated with Constant score and effects of 8 variables: Age, sex, pretreatment symptom duration, dominant shoulder, initial Constant score, active range of motion, acromion morphology, and acromial spur on patient outcomes were evaluated with univariate and multivariate analyses. RESULTS: Among 89 patients (44 men; mean age, 56.4 years) who finished the study, the mean difference between initial and final scores was 15.9 (95% confidence interval [CI]: 13.9-17.8). Three variables, the initial Constant score (b = .52, 95% CI: .28-.76), the duration of disease before treatment (b = -4.4, 95% CI: from -7.2 to -1.6), and acromial morphology (b = -5.3, 95% CI: from -9.8 to -.8) were found to be independent predictors of outcome (model R2 = .68). CONCLUSION: Patients with more severe disease, a long duration of symptoms, and type II or III acromion may require more invasive therapeutic options as the first intervention.
|
Authors | Afsin Taheriazam, Mohsen Sadatsafavi, Alireza Moayyeri |
Journal | MedGenMed : Medscape general medicine
(MedGenMed)
Vol. 7
Issue 1
Pg. 63
(Feb 14 2005)
ISSN: 1531-0132 [Electronic] United States |
PMID | 16369368
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Anti-Inflammatory Agents, Non-Steroidal
- Indomethacin
|
Topics |
- Adrenal Cortex Hormones
(therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Female
- Humans
- Indomethacin
(therapeutic use)
- Longitudinal Studies
- Male
- Middle Aged
- Physical Therapy Modalities
- Prognosis
- Shoulder Impingement Syndrome
(diagnosis, therapy)
- Treatment Outcome
|